Keywords: nice, relaxes, guidance, gw, relenza, now, use

NICE relaxes guidance on GW's Relenza, now for use on NHS in high-risk

Article | 21 November 2000

Print This

Glaxo Wellcome's influenza drug Relenza (zanamivir) has been recommendedfor use in treating at-risk adults when flu is circulating in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in